| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |